These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30413001)

  • 1. A Nationwide Survey on Danon Disease in Japan.
    Sugie K; Komaki H; Eura N; Shiota T; Onoue K; Tsukaguchi H; Minami N; Ogawa M; Kiriyama T; Kataoka H; Saito Y; Nonaka I; Nishino I
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30413001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early onset of cardiomyopathy and intellectual disability in a girl with Danon disease associated with a de novo novel mutation of the LAMP2 gene.
    Sugie K; Yoshizawa H; Onoue K; Nakanishi Y; Eura N; Ogawa M; Nakano T; Sakaguchi Y; Hayashi YK; Kishimoto T; Shima M; Saito Y; Nishino I; Ueno S
    Neuropathology; 2016 Dec; 36(6):561-565. PubMed ID: 27145725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Danon disease: a phenotypic expression of LAMP-2 deficiency.
    Endo Y; Furuta A; Nishino I
    Acta Neuropathol; 2015 Mar; 129(3):391-8. PubMed ID: 25589223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic and clinical aspects of Danon disease in a patient with a mutation c.137G > A in the LAMP-2 gene.
    Fidzianska A; Madej-Pilarczyk A; Walczak E; Kuch M
    Neuropediatrics; 2013 Oct; 44(5):276-80. PubMed ID: 23504560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of LAMP2 Mutations in Early-Onset Danon Disease With Hypertrophic Cardiomyopathy by Targeted Next-Generation Sequencing.
    Fu L; Luo S; Cai S; Hong W; Guo Y; Wu J; Liu T; Zhao C; Li F; Huang H; Huang M; Wang J
    Am J Cardiol; 2016 Sep; 118(6):888-894. PubMed ID: 27460667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 13-year-old girl with proximal weakness and hypertrophic cardiomyopathy with Danon disease.
    Kim H; Cho A; Lim BC; Kim MJ; Kim KJ; Nishino I; Hwang YS; Chae JH
    Muscle Nerve; 2010 Jun; 41(6):879-82. PubMed ID: 20513107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danon disease with typical early-onset cardiomyopathy in a male: focus on a novel LAMP-2 mutation.
    Bui YK; Renella P; Martinez-Agosto JA; Verity A; Madikians A; Alejos JC
    Pediatr Transplant; 2008 Mar; 12(2):246-50. PubMed ID: 18282207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A family with Danon disease caused by a splice site mutation in LAMP2 that generates a truncated protein.
    Zhou N; Cui J; Zhao W; Jiang Y; Zhu W; Tang L; Li X; Sun M; Pan C; Shu X
    Mol Genet Genomic Med; 2019 Mar; 7(3):e561. PubMed ID: 30714332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Consensus on Differential Diagnosis and Management of Patients With Danon Disease: JACC State-of-the-Art Review.
    Hong KN; Eshraghian EA; Arad M; Argirò A; Brambatti M; Bui Q; Caspi O; de Frutos F; Greenberg B; Ho CY; Kaski JP; Olivotto I; Taylor MRG; Yesso A; Garcia-Pavia P; Adler ED
    J Am Coll Cardiol; 2023 Oct; 82(16):1628-1647. PubMed ID: 37821174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease.
    Fanin M; Nascimbeni AC; Fulizio L; Spinazzi M; Melacini P; Angelini C
    Am J Pathol; 2006 Apr; 168(4):1309-20. PubMed ID: 16565504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danon disease as a cause of autophagic vacuolar myopathy.
    Yang Z; Vatta M
    Congenit Heart Dis; 2007; 2(6):404-9. PubMed ID: 18377432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LAMP-2 deficiency leads to hippocampal dysfunction but normal clearance of neuronal substrates of chaperone-mediated autophagy in a mouse model for Danon disease.
    Rothaug M; Stroobants S; Schweizer M; Peters J; Zunke F; Allerding M; D'Hooge R; Saftig P; Blanz J
    Acta Neuropathol Commun; 2015 Jan; 3():6. PubMed ID: 25637286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children.
    Yang Z; McMahon CJ; Smith LR; Bersola J; Adesina AM; Breinholt JP; Kearney DL; Dreyer WJ; Denfield SW; Price JF; Grenier M; Kertesz NJ; Clunie SK; Fernbach SD; Southern JF; Berger S; Towbin JA; Bowles KR; Bowles NE
    Circulation; 2005 Sep; 112(11):1612-7. PubMed ID: 16144992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease).
    Nishino I; Fu J; Tanji K; Yamada T; Shimojo S; Koori T; Mora M; Riggs JE; Oh SJ; Koga Y; Sue CM; Yamamoto A; Murakami N; Shanske S; Byrne E; Bonilla E; Nonaka I; DiMauro S; Hirano M
    Nature; 2000 Aug; 406(6798):906-10. PubMed ID: 10972294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare and fatal cause of hypertrophic cardiomyopathy: Danon disease.
    Türkmen H; Uysal F; Bostan ÖM
    Cardiol Young; 2023 Aug; 33(8):1448-1450. PubMed ID: 36601912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Danon disease due to a novel splice mutation in the LAMP2 gene.
    Nadeau A; Therrien C; Karpati G; Sinnreich M
    Muscle Nerve; 2008 Mar; 37(3):338-42. PubMed ID: 18004770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic stroke due to hypoperfusion in a patient with a previously unrecognized Danon disease.
    Marino M; Musumeci O; Paleologo G; Cucinotta M; Migliorato A; Rodolico C; Toscano A
    Neuromuscul Disord; 2016 Dec; 26(12):890-894. PubMed ID: 27816333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Danon disease: a novel LAMP2 mutation affecting the pre-mRNA splicing and causing aberrant transcripts and partial protein expression.
    Di Blasi C; Jarre L; Blasevich F; Dassi P; Mora M
    Neuromuscul Disord; 2008 Dec; 18(12):962-6. PubMed ID: 18990578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic heterogeneity in two unrelated Danon patients associated with the same LAMP-2 gene mutation.
    Bertini E; Donati MA; Broda P; Cassandrini D; Petrini S; Dionisi-Vici C; Ballerini L; Boldrini R; D'Amico A; Pasquini E; Minetti C; Santorelli FM; Bruno C
    Neuropediatrics; 2005 Oct; 36(5):309-13. PubMed ID: 16217705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel LAMP2 mutation associated with severe cardiac hypertrophy and microvascular remodeling in a female with Danon disease: a case report and literature review.
    Bottillo I; Giordano C; Cerbelli B; D'Angelantonio D; Lipari M; Polidori T; Majore S; Bertini E; D'Amico A; Giannarelli D; De Bernardo C; Masuelli L; Musumeci F; Avella A; Re F; Zachara E; d'Amati G; Grammatico P
    Cardiovasc Pathol; 2016; 25(5):423-31. PubMed ID: 27497751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.